Weian Zhang

Prof. Weian Zhang


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 July 2021 in Nature Materials
Verified
Journal Article
Closed access
PDF file
TWTing Wang
Ting Wang
Wang ShangfengWang Shangfeng
Wang Shangfeng
ZLZhiyong Liu
Zhiyong Liu
ZHZuyang He
Zuyang He
PYPeng Yu
Peng Yu
FZFan Zhang
Fan Zhang

1 August 2019 in Progress in Polymer Science
Verified
Journal Article
Closed access
JTJia Tian
Jia Tian
WZWeian Zhang
Weian Zhang

12 December 2014 in Polymer Chemistry
Verified
Journal Article
Closed access
PDF file
LLLichao Liu
Lichao Liu
LRLeilei Rui
Leilei Rui
YGYun Gao
Yun Gao
WZWeian Zhang
Weian Zhang
The synthesis and self-assembly of ferrocene-containing block copolymers PEG-b-PMAEFc, and the encapsulation and redox-responsive release of a model molecule (rhodamine B) upon external redox stimuli (H2O2).

14 November 2018 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
JJJianqiu Jin
Jianqiu Jin
YZYucheng Zhu
Yucheng Zhu
ZZZhenghe Zhang
Zhenghe Zhang
WZWeian Zhang
Weian Zhang

29 April 2019 in Chemical Science
Verified
Journal Article
Open access
PDF file
GYGuoliang Yang
Guoliang Yang
JTJia Tian
Jia Tian
CCChao Chen
Chao Chen
DJDawei Jiang
Dawei Jiang
YXYudong Xue
Yudong Xue
WZWeian Zhang
Weian Zhang
The efficacy of photodynamic therapy and chemotherapy is largely limited by oxygen deficiency in the hypoxic tumor microenvironment. To solve these problems, we fabricated a novel NIR-responsive nanosystem which could co-deliver oxygen and anticancer drug DOX. An oxygen self-sufficient amphiphile (F-IR780-PEG) was first synthesized and subsequently utilized to load anticancer drug DOX to form nanoparticles (F/DOX nanoparticles). Due to the high oxygen capacity of such nanoparticles, the hypoxic tumor microenvironment was greatly modulated after these nanoparticles reached the tumor region, and the results revealed that hypoxia-inducible factor α (HIF-1α) was down-regulated and the expression of P-glycoprotein (P-gp) was then reduced, which were in favor of chemotherapy. Under light irradiation at 808 nm, IR780 could efficiently produce singlet oxygen to damage cancer cells by photodynamic therapy (PDT). Simultaneously, the IR780 linkage could be cleaved by singlet oxygen generated by itself and resulted in DOX release, which further caused cell damage by chemotherapy. With the combination of PDT and chemotherapy, F/DOX nanoparticles showed remarkable therapeutic efficacy under in vitro and in vivo conditions. Furthermore, the F/DOX nanoparticles are favorable for imaging-guided tumor therapy due to the inherent fluorescence properties of IR780. We thus believe that the synergistic treatment described here leads to an ideal therapeutic approach to hypoxic tumors.

30 May 2019 in Biomaterials Science
Verified
Journal Article
Closed access
PDF file
YZYuanhao Zhang
Yuanhao Zhang
MCMingjiao Chen
Mingjiao Chen
JTJia Tian
Jia Tian
PGPing Gu
Ping Gu
HCHongliang Cao
Hongliang Cao
WZWeian Zhang
Weian Zhang
Stem cell therapy based on advanced biomaterials provides a promising strategy in bone tissue engineering. Nevertheless, guided bone regeneration which fulfills the criteria in terms of biomechanics, biodegradability and bioactivity is highly appealing but challenging. Inspired by the superior double-network (DN) structure, herein, a biodegradable hybrid DN hydrogel is proposed to promote in situ bone regeneration. The DN hydrogel is constructed by interspersing a methacrylated gelatin (GelMA) network into a well-defined nanocomposite (NC) hydrogel consisting of methacrylated chitosan (CSMA) and polyhedral oligomeric silsesquioxane (POSS) via a two-step photo-crosslinking process. The hybrid DN hydrogel has the following advantageous characteristics: (i) it exhibits enhanced stiffness and toughness benefiting from the inorganic POSS units and unique energy dissipation; (ii) naturally occurring biomacromolecules (chitosan and gelatin) as the hydrogel framework result in an appropriate biodegradation behavior, which can be replaced by newly formed tissues; (iii) it preferentially guides mesenchymal stem cells (MSCs) toward osteogenic differentiation in vitro by detecting the elevated levels of enzyme activity and calcium deposition along with the up-regulated osteogenesis-related genes and proteins; and (iv) accelerated in situ bone regeneration is observed after implanting MSC-loaded hydrogels into rat calvarial defects. Therefore, we provide a new insight to develop functional hydrogels for triggering specific cellular responses toward stem cell therapy and bone-related tissue engineering.